PDIA4 and infection: Of the 3 inhibitors tested (DTNB, 16F16 and PACMA31) only 16F16, a cell permeable inhibitor that had been reported to inhibit the enzymatic activity of PDIA4 [16], showed an inhibitory effect on HAstV-8 infection (Figure 4A).